Shijia Yan

490 total citations
9 papers, 348 citations indexed

About

Shijia Yan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Shijia Yan has authored 9 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Shijia Yan's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Shijia Yan is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (2 papers) and Nanoplatforms for cancer theranostics (1 paper). Shijia Yan collaborates with scholars based in China and United States. Shijia Yan's co-authors include Guohui Wan, Lei Sun, Arabella Wan, Heng Liang, Xianzhang Bu, Yi Niu, Ziyou Lin, Weiling He, Dongshi Chen and Xiongbin Lu and has published in prestigious journals such as Nature Communications, Gastroenterology and Hepatology.

In The Last Decade

Shijia Yan

8 papers receiving 347 citations

Peers

Shijia Yan

MB

CR

IMMUN

ONCOL

PRM

Xuxin Ren China

Da Zeng China

Zhenzhen Xun China

Ruizhi Fan China

Luan Sun China

Chenglai Dong China

Inês A. Batista Portugal

Sarah Owen United States

Lynette M. Phillips United States

Jian-Ping Huo China

Xuxin Ren China

Shijia Yan

282 ×1.1

MB

149 ×1.0

CR

85 ×1.2

IMMUN

98 ×1.5

ONCOL

38 ×1.1

PRM

Citations per year, relative to Shijia Yan Shijia Yan (= 1×) peers Xuxin Ren

Countries citing papers authored by Shijia Yan

Since Specialization

Citations

This map shows the geographic impact of Shijia Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shijia Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shijia Yan more than expected).

Fields of papers citing papers by Shijia Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shijia Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shijia Yan. The network helps show where Shijia Yan may publish in the future.

Co-authorship network of co-authors of Shijia Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Shijia Yan. A scholar is included among the top collaborators of Shijia Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shijia Yan. Shijia Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Liu, Chuwei, Peipei Wang, Yuyan Zheng, et al.. (2025). HNRNPA2B1 Orchestrates Immune Evasion in Colorectal Cancer by Rewiring Tumor–Immune Cell Interactions and Suppressing CD8+ T-cell Infiltration. Cancer Immunology Research. 14(1). 60–76.

2.

Liu, Chuwei, Heng Liang, Arabella Wan, et al.. (2025). Decoding the m6A epitranscriptomic landscape for biotechnological applications using a direct RNA sequencing approach. Nature Communications. 16(1). 798–798. 9 indexed citations

3.

Gu, Tingxuan, Xiaorong Fu, Xueli Tian, et al.. (2024). Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis. Biomedicine & Pharmacotherapy. 174. 116603–116603. 6 indexed citations

4.

Sun, Lei, Zhengyu Liu, Arabella Wan, et al.. (2023). Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer. Gastroenterology. 166(3). 466–482. 16 indexed citations

5.

Sun, Lei, Arabella Wan, Shijia Yan, et al.. (2023). A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance. Acta Pharmaceutica Sinica B. 14(1). 223–240. 15 indexed citations

6.

Lin, Ziyou, Arabella Wan, Lei Sun, et al.. (2022). N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Molecular Therapy. 31(2). 517–534. 56 indexed citations

7.

Niu, Yi, Ziyou Lin, Arabella Wan, et al.. (2021). Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia. Hepatology. 74(3). 1461–1479. 91 indexed citations

8.

Yan, Shijia & Guohui Wan. (2021). Tumor‐associated macrophages in immunotherapy. FEBS Journal. 288(21). 6174–6186. 69 indexed citations

9.

Sun, Lei, Arabella Wan, Zhuolong Zhou, et al.. (2020). RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut. 70(9). 1698–1712. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact